The U.S. Pharmacopeia (USP) and Mestrelab Research, S.L. (Mestrelab)

FHS
April 18, 2024
12:54 pm

The U.S. Pharmacopeia (USP) and Mestrelab Research, S.L. (Mestrelab), are pleased to announce they have entered into a collaboration to deliver USP-ID, through Mestrelab’s Mnova platform.

Ongoing bird flu outbreak makes Finnish authorities to cull 120,000 animals

Finnish authorities have said that due to the ongoing outbreak of Highly pathogenic H5N1 bird flu on 25 farms across the country they will now

August 25, 2023

Pharmalittle: We’re reading about BIO cutting ties with WuXi, EU pharma rules, and more

Rise and shine, everyone, another busy day is on the way. We can tell because the official mascots are especially enjoying the Pharmalot grounds now

March 14, 2024

Risk Adjusted Net Present Value: What is the current valuation of AnaptysBio’s Rosnilimab

The revenue for Rosnilimab is expected to reach an annual total of $9 mn by 2039 globally based off GlobalData’s Expiry Model. The drug’s revenue

August 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.